NCT06565416 Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
| NCT ID | NCT06565416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of New Mexico |
| Condition | Opioid Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 225 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 225 participants in total. It began in 2023-06-01 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
Eligibility Criteria
Inclusion Criteria: * Willing and able to provide informed consent * have English comprehension and proficiency * receiving services at one of our participating study sites * report current chronic pain and/or opioid misuse/opioid use disorder * self-identify as American Indian/Alaska Native Exclusion Criteria: * if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process
Contact & Investigator
Matthew R Pearson, PhD
PRINCIPAL INVESTIGATOR
University of New Mexico
Frequently Asked Questions
Who can join the NCT06565416 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06565416 currently recruiting?
Yes, NCT06565416 is actively recruiting participants. Contact the research team at kamilla@unm.edu for enrollment information.
Where is the NCT06565416 trial being conducted?
This trial is being conducted at Arcata, United States, Minneapolis, United States, Toppenish, United States.
Who is sponsoring the NCT06565416 clinical trial?
NCT06565416 is sponsored by University of New Mexico. The principal investigator is Matthew R Pearson, PhD at University of New Mexico. The trial plans to enroll 225 participants.